A massive production studio and waterfront development site in downtown Catskill is heading to auction, offering a rare ...
16h
Localsyr.com on MSNFish Creek in Sylvan Beach seems to have crestedIt's not just the heavy rain and gusty winds causing concern; it's a combination of that, and melting snow. The warmer ...
Sylvan Beach, NY -- A flood watch will be in effect Sunday for a wide swath of Central New York due to the combination of rapid snow melt and forecasted rain.
Motorists on Interstate 81 in Broome County will soon see new signs that implement a mileage-based numbering system for exits ...
In Tuxedo Park, New York, this sprawling 9,000-square-foot castle-like home that’s perched on 15 private acres, is up for grabs after more than 20 years, The Post has learned. It’s asking $6.2 ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Monday’s wreck happened near the intersection of Wolf Road and Sand Creek Road, as Daily Voice reported. Holguin was traveling northbound on Wolf Road when he crossed the center line and collided head ...
About this data The size of Castle Creek is approximately 18 square kilometres. The population of Castle Creek in 2011 was 195 people. By 2016 the population was 68 showing a population decline of ...
Built in the early 1800s by the once-powerful Campbell clan, Taymouth Castle has had a bit of a bumpy road. After the Campbells sold it in 1922 to pay off gambling debts, it served as a hotel ...
Capital will fund Castle Creek’s D-Fi Phase 3 clinical trial for patients with dystrophic epidermolysis bullosa through topline data results Ligand invested $50 million and a syndicate of co-investors ...
(RTTNews) - Ligand Pharmaceuticals Inc. (LGND) Tuesday announced it has closed a royalty financing agreement with Castle Creek Biosciences ... Andrew Mariathasan in New York, with the goal ...
Ligand (LGND) Pharmaceuticals has closed a royalty financing agreement with Castle Creek Biosciences to support the Phase 3 clinical study of D-Fi, Castle Creek’s lead candidate, in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results